fundamental research of the cause of inflammatory bowel disease on Caco-2 cells mucosal model
fundamental research of the cause of inflammatory bowel disease on Caco-2 cells mucosal model
批准号:
15591895
负责人:
SAWAI Toshio
金额:
$1.92万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Mucosal model of Caco-2 cells, human colon cancer cells, was formed on wells. The 4 groups were made and incubated for 48 hours and 72 hours. One is that mucosal model was incubated without cytokine, another is that mucosal model was incubated with IL-1, the other with IL-6, the forth with TNF-α. The content of RNA was extracted from mucosa of each group. The expression of intracellular phospholipase A2 mRNA of each group was measured with Northern Blot, compared to the relative expression of β-actin. The expression of intracellular phospholipase A2 mRNA of IL-6 group was significantly increased than the others at 48 hours. At 72 hours, the expression of intracellular phospholipase A2 mRNA of TNF-α group was significantly increased than the others. Mucosal models were made on transwells with/without cytokine, to measure the transepithelial electrical resistance (TEER) at 6, 12, 24, 72 hours after the addition of cytokine.The TEER of IL-6 group was significantly higher compared to contr … More ol group at 6,12,24 hours. At 72 hours, the TEER of IL-1 and IL-6 group was significantly decreased than the control group. The proinflammatory cytokine IL-6 increased the expression of sPLA2 (a hydrolyzer of phosphatidylcholine) of both intracellular and media.Mucosal models were incubated for 72 h with IL-6 or media alone (control). Both media and cell lysate were analyzed for PL composition using thin-layer chromatography. The PL composition in the media did not show any differences between the two groups. Total intracellular PL contents were also unchanged ; however, IL-6 led to significant changes in PL composition including an increase in phosphatidylethanolamine(PE) and sphingomyelin(SM) and a decrease in phosphatidylcholine(PC) and lysophosphatidylcho-line(LPC) (p<0.05). Both PE and SM are known as inflammatory signaling factors involved in human IBD.Our study suggests that cytokine may change the mucosal permeability, however this change may not be the effect of lysophospholipids made from phospholipids by phospholipase A2. Less
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
健脾益髓解毒方下调S100A9介导NLRP3/IL-1β信号通路改善骨髓增生异常综合征造血微环境机制研究
-
批准号:JCZRQNB202600675
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
矾冰纳米乳靶控NLRP3介导IL-1β/TGF-β1轴清透“热气留滞”生肌不致成瘢的机制研究
-
批准号:2026JJ82090
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:魏源水
-
依托单位:
基于NLRP3/IL-1β/TGF-β1信号通路调控细胞焦亡探讨柴胡清肝汤治疗肉芽肿性乳腺炎的作用机制
-
批准号:2026JJ82398
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:吴世婷
-
依托单位:
早产儿脑白质损伤的 MRI 影像学特征联合炎症因子组合(IL-6、TNF-α、IL-1β)与神经系统损害关联研究
-
批准号:JCZRLH202601761
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
炎症因子组合(IL-6、TNF-α、IL-1β)动态监测在极低出生体重儿坏死性小肠结肠炎早期预测中的价值研究
-
批准号:JCZRLH202601488
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
煨脓生肌理论下糖足生肌散外敷联合保守性锐器清创调控NLRP3/IL-1β轴治疗2型糖尿病足溃疡(湿热毒盛证)的机制研究
-
批准号:2026JJ81429
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:梁玉兰
-
依托单位:
局灶性TBI早期IL-1β调控星形胶质细胞IL-1R1/NF-κB/LCN2信号通路造成脑损伤的机制研究
-
批准号:JCZRYB202500873
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
肠道微生物通过NLRP3/IL-1β通路介导血管内皮损伤在川崎病及其冠状动脉病变中的作用机制研究
-
批准号:JCZRLH202500452
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
靶向PGE2/CREBL2调节IL-1β+TAM分化抑制结直肠炎癌转变的研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:王俊
-
依托单位:
炎症因子IL-1β介导线粒体DNA释放抑制牛病毒性腹泻病毒复制的分子机制研究
-
批准号:QN25C180008
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:王孟孟
-
依托单位: